US regulators OK new COVID-19 shot option from Novavax

Österreich Nachrichten Nachrichten

US regulators OK new COVID-19 shot option from Novavax
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 WOKVNews
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 63%

The U.S. is getting another COVID-19 vaccine choice

as the Food and Drug Administration on Wednesday clearedNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.

Novavax CEO Stanley Erck told The Associated Press that he expected the U.S. to expand use of the vaccine beyond unvaccinated adults fairly quickly. Sharon Bentley of Argyle, Texas, is one of the holdouts. Bentley was hesitant about the first COVID-19 vaccines but then her husband volunteered for a Novavax trial, getting two doses and later a booster.

Protein vaccines have been used for years to prevent hepatitis B, shingles and other diseases. It’s a very different technology than the dominant Pfizer and Moderna COVID-19 vaccines that deliver genetic instructions for the body to produce its own copies of the spike protein. The lesser-used Johnson & Johnson option uses a harmless cold virus to deliver spike-making instructions.

subtypes — and Novavax also has begun testing updated shots. Erck said the company could have updated doses available late in the year.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

WOKVNews /  🏆 247. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Omicron subvariants threaten COVID-19 resurgence across USOmicron subvariants threaten COVID-19 resurgence across USHealth officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S.
Weiterlesen »

US sees doubling in hospitalizations due to COVID-19 since April, reflecting spread of new subvariantsUS sees doubling in hospitalizations due to COVID-19 since April, reflecting spread of new subvariantsDr. Walensky said the U.S. has seen a doubling in the number of hospitalizations due to COVID-19 since April, reflecting the spread of the new subvariants, though deaths have remained steady around 300 per day.
Weiterlesen »

Masks urged in New York City as COVID-19 omicron subvariant BA.5 cases tick upMasks urged in New York City as COVID-19 omicron subvariant BA.5 cases tick upAs COVID-19 cases tick up in New York City, the Department of Health is continuing to urge residents to wear masks in all public indoor settings and in crowded areas outdoors.
Weiterlesen »

COVID-19 symptoms can linger for many weeks, CDC study saysCOVID-19 symptoms can linger for many weeks, CDC study saysThe symptoms could be a headache, a runny nose, a sore throat, as well as loss of smell, taste or hair. Some could even struggle with fatigue, chills or fever.
Weiterlesen »

New push to offer second COVID-19 booster to all adults amid new surge: reportNew push to offer second COVID-19 booster to all adults amid new surge: reportAll adults would become eligible for a second COVID-19 booster shot under a plan being worked on by the Biden administration, the Washington Post reported...
Weiterlesen »



Render Time: 2025-03-31 13:58:01